Karin Papworth

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Michele Maio, Karl D. Lewis, Lev Demidov et al. · The Lancet Oncology · 2018 · 210 citations · Full text

Medicine, Melanoma, Immunology +10

Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000‐2013

Sandra Eloranta, Elsa Brånvall, Fredrik Celsing et al. · European Journal Of Haematology · 2017 · 57 citations

Valproate in combination with rituximab and CHOP as first-line therapy in diffuse large B-cell lymphoma (VALFRID)

Kristina Drott, Hans Hagberg, Karin Papworth et al. · Blood Advances · 2018 · 30 citations · Full text

Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database

Philip J. Lupo, Heather E. Danysh, Sharon E. Plon et al. · Cancer Medicine · 2015 · 29 citations · Full text

Family Medicine, Oncology Group, Epidemiology Of Cancer +16

Allergies, atopy, immune‐related factors and childhood rhabdomyosarcoma: A report from the children's oncology group

Philip J. Lupo, Renke Zhou, Stephen X. Skapek et al. · International Journal of Cancer · 2013 · 27 citations · Full text

Asthma, Oncology Group, Environmental Allergy +21